Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorMassachusetts General Hospital

About this trial

In the current study, the investigators aim to understand the role of transcranial direct current stimulation (tDCS) in improving executive function across neuropsychiatric populations known to have deficits in this cognitive domain.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Male and female outpatients 18-65 years of age

A diagnosis of traumatic brain injury, major depressive disorder, bipolar disorder, schizophrenia, attention deficit hyperactivity disorder, borderline personality disorder and substance use disorders meeting the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria.

Disqualifiers

Contraindication to tDCS: history or epilepsy, metallic implants in the head and neck, brain stimulators, vagus nerve stimulators, shunts, pacemakers, pregnancy.

Active substance dependence (except for tobacco and cannabis).

Pregnant or nursing females.

Inability to participate in testing procedures.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Transcranial Direct Current Stimulation

    Device

    In tDCS, electrodes are applied on the scalp to transmit direct current at low current amplitudes.

Treatment groups

600 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Group A: Traumatic Brain InjuryExperimental treatment 1 intervention
Group B: Major Depressive DisorderExperimental treatment 1 intervention
Group C: Bipolar DisorderExperimental treatment 1 intervention
Group D: SchizophreniaExperimental treatment 1 intervention
Group E: Attention Deficit Hyperactivity DisorderExperimental treatment 1 intervention
Group F: Borderline Personality DisorderExperimental treatment 1 intervention
Group G: Substance Use DisorderExperimental treatment 1 intervention
Group H: Healthy ControlsActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in N-Back Task

Working Memory Task

Time frame
Baseline to Post-Treatment, 1 Week

Secondary outcomes

1

Change in Flanker Task

Attention and Inhibitory Control Task

Time frame
Baseline to Post-Treatment, 1 Week
2

Change in Multi-Source Interference with International Affective Picture System Task

Cognitive Control During Emotional Regulation Task

Time frame
Baseline to Post-Treatment, 1 Week
3

Change in Delayed Discounting Task

Decision-Making Task

Time frame
Baseline to Post-Treatment, 1 Week
4

Change in Stop Signal Task

Ability to Inhibit a Response Task

Time frame
Baseline to Post-Treatment, 1 Week

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.